Novavax OverviewNovavax EBIT
EBIT (Earnings Before Interest and Taxes) analysis for NVAX.
Quarterly EBIT
-$15.43M
↓ 102.99% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$23.30M
↓ 104.89% YoY
Trailing 12 months ending Mar 31, 2026
Novavax OverviewEBIT (Earnings Before Interest and Taxes) analysis for NVAX.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026